Innovation Medical Management Co., Ltd.
Symbool: 002173.SZ
SHZ
8.86
CNYMarktprijs vandaag
-107.2347
Koers/Winst Verhouding
0.1986
Koers/Winst Groei Verhouding
3.91B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Innovation Medical Management Co., Ltd. (002173-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2371.68 | 583.2 | 658.5 | 799.8 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | -32.02 | 20.1 | 0 | 574 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 410.45 | 107 | 60.9 | 94.3 | ||||||||||||||||||||
balance-sheet.row.inventory | 157.59 | 41.8 | 49.3 | 43 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 8.09 | 1.1 | 3 | 2.9 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 2947.81 | 733.1 | 771.6 | 940 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 5372.28 | 1349.8 | 1375.5 | 1397 | ||||||||||||||||||||
balance-sheet.row.goodwill | 3.95 | 1 | 1 | 1 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 502.52 | 129.6 | 121.8 | 125.2 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 506.47 | 130.5 | 122.8 | 126.2 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 94.5 | -4.9 | 17.9 | -554.3 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 59.97 | 17 | 14.4 | 13.8 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 117.43 | 55.9 | 37.4 | 633.5 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 6150.64 | 1548.4 | 1568 | 1616.2 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 9098.45 | 2281.5 | 2339.7 | 2556.2 | ||||||||||||||||||||
balance-sheet.row.account-payables | 766.16 | 208.1 | 210.1 | 183.4 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 157.13 | 48.2 | 36.9 | 29.9 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 18.08 | 6.6 | 5.8 | 5.9 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 80.78 | 20.3 | 21.6 | 33.9 | ||||||||||||||||||||
Deferred Revenue Non Current | 16.99 | 4.2 | 4.8 | 5.2 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 177.64 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 58.66 | 0 | 70.1 | 46 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 338.5 | 85 | 112 | 219.3 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 80.78 | 20.3 | 21.6 | 33.9 | ||||||||||||||||||||
balance-sheet.row.total-liab | 1566.11 | 410.4 | 434.4 | 565.3 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 1800.21 | 449 | 453.1 | 453.6 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -5168.47 | -1304.2 | -1269.7 | -1184.2 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 2861 | 43.8 | 43.4 | 40.1 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 8035.94 | 2681.5 | 2677.5 | 2680.3 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 7528.69 | 1870.2 | 1904.3 | 1989.8 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 9098.45 | 2281.5 | 2339.7 | 2556.2 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 3.65 | 0.9 | 0.9 | 1.1 | ||||||||||||||||||||
balance-sheet.row.total-equity | 7532.33 | 1871.1 | 1905.2 | 1990.9 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 9098.45 | - | - | - | ||||||||||||||||||||
Total Investments | 62.48 | 15.2 | 17.9 | 19.8 | ||||||||||||||||||||
balance-sheet.row.total-debt | 237.91 | 68.5 | 58.4 | 63.8 | ||||||||||||||||||||
balance-sheet.row.net-debt | -2093.02 | -494.5 | -600.1 | -161.9 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -35.11 | -34.3 | -73.9 | -105.1 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.63 | 106.7 | 110.3 | 117.5 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -3.2 | -1.4 | -3.9 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 3.2 | 1.4 | 3.9 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -79.95 | -43 | 9.8 | 18.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | -49.07 | -49.1 | 36 | 11.7 | ||||||||||||||||||||
cash-flows.row.inventory | 6.82 | 6.8 | -6.7 | -8 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 2.4 | -18.1 | 19.1 | ||||||||||||||||||||
cash-flows.row.other-working-capital | -37.7 | -3.2 | -1.4 | -3.9 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 89.42 | -18.3 | -70.7 | 12 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -19.01 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -90.18 | -96.2 | -123.2 | -110.7 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.13 | 0.3 | 0.2 | 35.6 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -320.4 | -320 | -30 | -695 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 625.03 | -0.3 | 612.7 | 710.5 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -14.96 | 0.9 | 0.3 | 7.2 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -104.93 | -415.3 | 460 | -52.4 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -63 | -23 | -12 | -33 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 48.4 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -48.4 | ||||||||||||||||||||
cash-flows.row.dividends-paid | -1.66 | -1.5 | -0.8 | -2.4 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 50.2 | -10.5 | 9.8 | -76.1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 11.54 | -5 | -3 | -111.4 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.03 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -112.43 | -409.3 | 432.6 | -120.4 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2002.99 | 249 | 658.3 | 225.7 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2115.42 | 658.3 | 225.7 | 346.1 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -19.01 | 11 | -24.4 | 43.4 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -90.18 | -96.2 | -123.2 | -110.7 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -109.18 | -85.2 | -147.6 | -67.4 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 802.72 | 805.6 | 709.7 | 711.5 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 714.85 | 713.4 | 679.1 | 665.4 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 87.87 | 92.2 | 30.6 | 46.2 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 25.73 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 9.18 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -8.35 | -9.3 | 83.7 | 83 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 122.74 | 126.4 | 122.5 | 125.5 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 837.59 | 839.8 | 801.6 | 790.9 | ||||||||||||||||||||
income-statement-row.row.interest-income | 18.57 | 17.4 | 14.6 | 13.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 3.49 | 3.6 | 3.4 | 6.1 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 9.18 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -8.35 | -9.3 | -3.7 | 2.3 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -8.35 | -9.3 | 83.7 | 83 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -8.35 | -9.3 | -3.7 | 2.3 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 3.49 | 3.6 | 3.4 | 6.1 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -2.41 | 106.7 | 110.3 | 117.5 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | -29.94 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | -27.53 | -25.6 | -71.6 | -107.2 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | -35.87 | -35 | -75.3 | -104.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -0.7 | -0.7 | -1.4 | 0.3 | ||||||||||||||||||||
income-statement-row.row.net-income | -35.11 | -34.3 | -73.9 | -105.1 |
Vaak gestelde vragen
Wat is Innovation Medical Management Co., Ltd. (002173.SZ) totale activa?
Innovation Medical Management Co., Ltd. (002173.SZ) totale activa is 2281472772.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 399763679.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.109.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.044.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.034.
Wat is Innovation Medical Management Co., Ltd. (002173.SZ) nettowinst (netto-inkomen)?
De nettowinst is -34287743.350.
Wat is de totale schuld van het bedrijf?
De totale schuld is 68543479.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 126432642.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 543823060.000.